MTCM
AMED

Mint Tower Capital Management’s Amedisys AMED Stock Holding History

Mint Tower Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$98K – 202
2025
Q2 		$98K Buy
+1,000
New +$94.6K 0.01% 108
2024
Q3 		– Sell
-10,000
Closed -$918K – 154
2024
Q2 		$918K Buy
+10,000
New +$928K 0.29% 52
2023
Q3 		– Sell
-4,110
Closed -$376K – 273
2023
Q2 		$376K Buy
+4,110
New +$337K 0.04% 157

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mint Tower Capital Management's AMED Position: Q3 2025 in Review

Mint Tower Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,000 shares — an estimated $98K sold.

Mint Tower Capital Management first reported a position in AMED in Q2 2023 and held it in 3 quarters. The position peaked at $918K in Q2 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mint Tower Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,000 Amedisys shares in Q3 2025, an estimated $98K.
  • Mint Tower Capital Management first reported a position in Amedisys in Q2 2023 and held it in 3 quarters.
  • Mint Tower Capital Management's Amedisys position peaked at $918K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mint Tower Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.